Last edition
News about "Diabetic foot ulcers"
INTENT Biologics Secures FDA Breakthrough Therapy Tag for Diabetic Foot Ulcer Treatment Candidate
INTENT Biologics' PEP Biologic receives FDA Breakthrough Therapy designation for diabetic foot ulcers, accelerating development of its first-in-class exosome-based regenerative treatment aimed at improving healing outcomes in chronic wounds.
Diabetic Foot Ulcers | 03/07/2026 | By News Bureau
Lakewood-Amedex Biotherapeutics Reports Promising AMR Data for Nu-3 in Diabetic Foot Ulcer Treatment
Lakewood-Amedex advances Nu-3 as a potential breakthrough topical therapy to combat antibiotic-resistant infections in diabetic foot ulcers.
Diabetic Foot Ulcers | 01/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy